Capayosa, Gabriel .

HRN: 22-71-42  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/07/2026
08/13/2026
IVT
490mg
Q6H
PCAP B; T/C UTI
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: